EUVIMEDEUVIMED entdecken
Open Access

Claudin 18.2 Expression in 1404 Digestive Tract Adenocarcinomas Including 1175 Colorectal Carcinomas: Distinct Colorectal Carcinoma Subtypes Are Claudin 18.2 Positive

Kelsey E McHugh, Rish K Pai, Robert C Grant, Steven Gallinger, Jon Davison, Changqing Ma, Reetesh K Pai

Modern Pathology · 2025-05 · 38 (5) · 100712

DOI: 10.1016/j.modpat.2025.100712 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2025-05. Verfasst von Kelsey E McHugh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, Arizona. Hauptthemen laut MEDLINE: Claudins, Adenocarcinoma, Biomarkers, Tumor, Colorectal Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClaudinsAdenocarcinomaBiomarkers, TumorColorectal NeoplasmsHumansFemaleMaleMiddle AgedAgedImmunohistochemistryAdultAged, 80 and overTissue Array Analysis

Stichwörter der Autor:innen

Claudin 18.2HER2colorectal carcinomamicrosatellite instabilitymismatch repairmucinous adenocarcinoma

Substanzen

ClaudinsBiomarkers, TumorCLDN18 protein, human

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, Arizona.
  • Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
  • Department of Pathology, University of Pittsburgh Medical Center and the University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Department of Pathology and Immunology, Washington University, St. Louis, Missouri.
  • Department of Pathology, University of Pittsburgh Medical Center and the University of Pittsburgh, Pittsburgh, Pennsylvania. Electronic address: pair@upmc.edu.

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • National Institutes of Health

Zitieren

APA

McHugh, K. E., Pai, R. K., Grant, R. C., Gallinger, S., Davison, J., Ma, C., & Pai, R. K. (2025). Claudin 18.2 Expression in 1404 Digestive Tract Adenocarcinomas Including 1175 Colorectal Carcinomas: Distinct Colorectal Carcinoma Subtypes Are Claudin 18.2 Positive. Modern Pathology, 38(5), 100712. https://doi.org/10.1016/j.modpat.2025.100712

Vancouver

McHugh KE, Pai RK, Grant RC, Gallinger S, Davison J, Ma C, et al. Claudin 18.2 Expression in 1404 Digestive Tract Adenocarcinomas Including 1175 Colorectal Carcinomas: Distinct Colorectal Carcinoma Subtypes Are Claudin 18.2 Positive. Modern Pathology. 2025;38(5):100712. doi:10.1016/j.modpat.2025.100712

BibTeX
@article{McHugh2025,
  author = {McHugh, Kelsey E and Pai, Rish K and Grant, Robert C and Gallinger, Steven and Davison, Jon and Ma, Changqing and Pai, Reetesh K},
  title = {Claudin 18.2 Expression in 1404 Digestive Tract Adenocarcinomas Including 1175 Colorectal Carcinomas: Distinct Colorectal Carcinoma Subtypes Are Claudin 18.2 Positive},
  journal = {Modern Pathology},
  year = {2025},
  volume = {38},
  number = {5},
  pages = {100712},
  doi = {10.1016/j.modpat.2025.100712}
}
Kostenlos starten →